Michael Patrick Miller

Puma Biotechnology, Inc.Jazz Pharmaceuticals plc

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 1 saleDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (7 ops.)

€420k

Latest filing published 13 Nov 2025 for Puma Biotechnology, INC., €84k. Read the official filing

Filing timeline

BuySale

Michael Patrick Miller

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Michael Patrick Miller: trading record in brief

This profile gathers the share dealings of Michael Patrick Miller across 2 companies, led by Puma Biotechnology, Inc. and Jazz Pharmaceuticals plc. In total, 11 filings cover trades dated from 15 January 2016 to 11 November 2025.

The open-market record consists of 7 sales worth €420k, with no purchase. No amount is published for 1 filing, which the totals therefore leave out. Other entries cover 4 share grants. 2025 to date brings no purchases and 1 sale.

The latest filing, published on 13 November 2025, reports an open-market sale of €84k in Puma Biotechnology, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.